Skip to content

Compare U.S. Stocks

Put up to three companies side by side on valuation, growth, profitability, and debt.

Compare within a sector
MetricGSKGSK plcSNYSanofi SABMYBristol Myers Squibb
Snapshot
Price$52.43$45.40$66.31
Market cap$102.51B$98.73B$118.71B
Valuation
P/E13.8x7.4x23.3x
Forward P/E9.8x5.3x18.4x
Growth
Revenue growth4.0%43.7%1.8%
EPS growth86.7%96.2%26.3%
Profitability
Net margin17.8%17.2%12.3%
ROE35.8%17.0%41.6%
Balance sheet & cash
Debt / equity1.08x0.28x2.44x
Free cash flow yield3.8%21.4%15.4%
Dividend yield3.5%5.4%4.5%
Verdict
Investment ratingFavorable· 66Strong· 80Favorable· 60

5-Year Price Projections

Base case

Projected using each stock's current EPS, growth rate (EPS or revenue growth), and P/E ratio. P/E assumed to compress 25% on the low end and remain steady on the high end. Not a forecast — for comparative analysis only.

YearGSKtoday $52SNYtoday $45BMYtoday $66
2027$73.43 – $107.69+105% CAGR$66.81 – $97.98+116% CAGR$62.80 – $92.10+39% CAGR
2028$137.11 – $201.09+96% CAGR$131.07 – $192.24+106% CAGR$79.29 – $116.30+32% CAGR
2029$256.03 – $375.50+93% CAGR$257.17 – $377.18+103% CAGR$100.12 – $146.85+30% CAGR
2030$478.08 – $701.18+91% CAGR$504.56 – $740.02+101% CAGR$126.43 – $185.43+29% CAGR
2031$892.71 – $1,309.31+90% CAGR$989.95 – $1,451.92+100% CAGR$159.64 – $234.14+29% CAGR
5-yr CAGR76.3% – 90.3%85.2% – 100.0%19.2% – 28.7%